Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Proc Natl Acad Sci U S A ; 110(3): 1083-8, 2013 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-23277570

RESUMO

Neuronal signal integration as well as synaptic transmission and plasticity highly depend on the morphology of dendrites and their spines. Nogo-A is a membrane protein enriched in the adult central nervous system (CNS) myelin, where it restricts the capacity of axons to grow and regenerate after injury. Nogo-A is also expressed by certain neurons, in particular during development, but its physiological function in this cell type is less well understood. We addressed this question in the cerebellum, where Nogo-A is transitorily highly expressed in the Purkinje cells (PCs) during early postnatal development. We used general genetic ablation (KO) as well as selective overexpression of Nogo-A in PCs to analyze its effect on dendritogenesis and on the formation of their main input synapses from parallel (PFs) and climbing fibers (CFs). PC dendritic trees were larger and more complex in Nogo-A KO mice and smaller than in wild-type in Nogo-A overexpressing PCs. Nogo-A KO resulted in premature soma-to-dendrite translocation of CFs and an enlargement of the CF territory in the molecular layer during development. Although spine density was not influenced by Nogo-A, the size of postsynaptic densities of PF-PC synapses was negatively correlated with the Nogo-A expression level. Electrophysiological studies revealed that Nogo-A negatively regulates the strength of synaptic transmission at the PF-PC synapse. Thus, Nogo-A appears as a negative regulator of PC input synapses, which orchestrates cerebellar connectivity through regulation of synapse morphology and the size of the PC dendritic tree.


Assuntos
Cerebelo/fisiologia , Proteínas da Mielina/fisiologia , Animais , Cerebelo/citologia , Dendritos/fisiologia , Dendritos/ultraestrutura , Fenômenos Eletrofisiológicos , Proteínas Ligadas por GPI/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Proteínas da Mielina/deficiência , Proteínas da Mielina/genética , Proteínas da Mielina/metabolismo , Neurônios/fisiologia , Neurônios/ultraestrutura , Proteínas Nogo , Receptor Nogo 1 , Células de Purkinje/fisiologia , Células de Purkinje/ultraestrutura , Receptores de Superfície Celular/metabolismo , Transmissão Sináptica/fisiologia
2.
Nature ; 455(7211): 351-7, 2008 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-18716623

RESUMO

The cerebral cortex develops through the coordinated generation of dozens of neuronal subtypes, but the mechanisms involved remain unclear. Here we show that mouse embryonic stem cells, cultured without any morphogen but in the presence of a sonic hedgehog inhibitor, recapitulate in vitro the major milestones of cortical development, leading to the sequential generation of a diverse repertoire of neurons that display most salient features of genuine cortical pyramidal neurons. When grafted into the cerebral cortex, these neurons develop patterns of axonal projections corresponding to a wide range of cortical layers, but also to highly specific cortical areas, in particular visual and limbic areas, thereby demonstrating that the identity of a cortical area can be specified without any influence from the brain. The discovery of intrinsic corticogenesis sheds new light on the mechanisms of neuronal specification, and opens new avenues for the modelling and treatment of brain diseases.


Assuntos
Diferenciação Celular , Córtex Cerebral/citologia , Córtex Cerebral/embriologia , Células-Tronco Embrionárias/citologia , Animais , Axônios/efeitos dos fármacos , Axônios/fisiologia , Diferenciação Celular/efeitos dos fármacos , Linhagem da Célula/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Células-Tronco Embrionárias/efeitos dos fármacos , Camundongos , Células Piramidais/efeitos dos fármacos , Alcaloides de Veratrum/farmacologia
3.
Proc Natl Acad Sci U S A ; 108(41): 17004-9, 2011 Oct 11.
Artigo em Inglês | MEDLINE | ID: mdl-21953697

RESUMO

α-Synuclein is an abundant brain protein that binds to lipid membranes and is involved in the recycling of presynaptic vesicles. In Parkinson disease, α-synuclein accumulates in intraneuronal inclusions often containing ubiquitin chains. Here we show that the ubiquitin ligase Nedd4, which functions in the endosomal-lysosomal pathway, robustly ubiquitinates α-synuclein, unlike ligases previously implicated in its degradation. Purified Nedd4 recognizes the carboxyl terminus of α-synuclein (residues 120-133) and attaches K63-linked ubiquitin chains. In human cells, Nedd4 overexpression enhances α-synuclein ubiquitination and clearance by a lysosomal process requiring components of the endosomal-sorting complex required for transport. Conversely, Nedd4 down-regulation increases α-synuclein content. In yeast, disruption of the Nedd4 ortholog Rsp5p decreases α-synuclein degradation and enhances inclusion formation and α-synuclein toxicity. In human brains, Nedd4 is present in pigmented neurons and is expressed especially strongly in neurons containing Lewy bodies. Thus, ubiquitination by Nedd4 targets α-synuclein to the endosomal-lysosomal pathway and, by reducing α-synuclein content, may help protect against the pathogenesis of Parkinson disease and other α-synucleinopathies.


Assuntos
Encéfalo/metabolismo , Complexos Endossomais de Distribuição Requeridos para Transporte/metabolismo , Ubiquitina-Proteína Ligases/metabolismo , alfa-Sinucleína/metabolismo , Sequência de Aminoácidos , Animais , Sítios de Ligação , Linhagem Celular , Complexos Endossomais de Distribuição Requeridos para Transporte/genética , Endossomos/metabolismo , Células HEK293 , Humanos , Técnicas In Vitro , Corpos de Lewy/metabolismo , Locus Cerúleo/metabolismo , Lisina/química , Lisossomos/metabolismo , Camundongos , Dados de Sequência Molecular , Ubiquitina-Proteína Ligases Nedd4 , Doença de Parkinson/etiologia , Doença de Parkinson/metabolismo , Ratos , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Substância Negra/metabolismo , Especificidade por Substrato , Complexos Ubiquitina-Proteína Ligase/genética , Complexos Ubiquitina-Proteína Ligase/metabolismo , Ubiquitina-Proteína Ligases/genética , Ubiquitinação , alfa-Sinucleína/química , alfa-Sinucleína/genética
4.
J Biol Chem ; 287(21): 17471-17482, 2012 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-22451661

RESUMO

In neurodegenerative diseases caused by extended polyglutamine (polyQ) sequences in proteins, aggregation-prone polyQ proteins accumulate in intraneuronal inclusions. PolyQ proteins can be degraded by lysosomes or proteasomes. Proteasomes are unable to hydrolyze polyQ repeat sequences, and during breakdown of polyQ proteins, they release polyQ repeat fragments for degradation by other cellular enzymes. This study was undertaken to identify the responsible proteases. Lysosomal extracts (unlike cytosolic enzymes) were found to rapidly hydrolyze polyQ sequences in peptides, proteins, or insoluble aggregates. Using specific inhibitors against lysosomal proteases, enzyme-deficient extracts, and pure cathepsins, we identified cathepsins L and Z as the lysosomal cysteine proteases that digest polyQ proteins and peptides. RNAi for cathepsins L and Z in different cell lines and adult mouse muscles confirmed that they are critical in degrading polyQ proteins (expanded huntingtin exon 1) but not other types of aggregation-prone proteins (e.g. mutant SOD1). Therefore, the activities of these two lysosomal cysteine proteases are important in host defense against toxic accumulation of polyQ proteins.


Assuntos
Catepsina L/metabolismo , Catepsina Z/metabolismo , Lisossomos/metabolismo , Peptídeos/metabolismo , Animais , Catepsina L/genética , Catepsina L/imunologia , Catepsina Z/genética , Catepsina Z/imunologia , Células HEK293 , Células HeLa , Humanos , Lisossomos/genética , Lisossomos/imunologia , Camundongos , Músculo Esquelético/imunologia , Músculo Esquelético/metabolismo , Células NIH 3T3 , Doenças Neurodegenerativas/genética , Doenças Neurodegenerativas/imunologia , Doenças Neurodegenerativas/metabolismo , Peptídeos/genética , Peptídeos/imunologia
5.
J Neurosci ; 31(33): 11795-807, 2011 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-21849540

RESUMO

The contribution of neuronal dysfunction to neurodegeneration is studied in a mouse model of spinocerebellar ataxia type 1 (SCA1) displaying impaired motor performance ahead of loss or atrophy of cerebellar Purkinje cells. Presymptomatic SCA1 mice show a reduction in the firing rate of Purkinje cells (both in vivo and in slices) associated with a reduction in the efficiency of the main glutamatergic synapse onto Purkinje cells and with increased A-type potassium current. The A-type potassium channel Kv4.3 appears to be internalized in response to glutamatergic stimulation in Purkinje cells and accumulates in presymptomatic SCA1 mice. SCA1 mice are treated with aminopyridines, acting as potassium channel blockers to test whether the treatment could improve neuronal dysfunction, motor behavior, and neurodegeneration. In acutely treated young SCA1 mice, aminopyridines normalize the firing rate of Purkinje cells and the motor behavior of the animals. In chronically treated old SCA1 mice, 3,4-diaminopyridine improves the firing rate of Purkinje cells, the motor behavior of the animals, and partially protects against cell atrophy. Chronic treatment with 3,4-diaminopyridine is associated with increased cerebellar levels of BDNF, suggesting that partial protection against atrophy of Purkinje cells is possibly provided by an increased production of growth factors secondary to the reincrease in electrical activity. Our data suggest that aminopyridines might have symptomatic and/or neuroprotective beneficial effects in SCA1, that reduction in the firing rate of Purkinje cells can cause cerebellar ataxia, and that treatment of early neuronal dysfunction is relevant in neurodegenerative disorders such as SCA1.


Assuntos
Aminopiridinas/uso terapêutico , Transtornos das Habilidades Motoras/prevenção & controle , Degeneração Neural/tratamento farmacológico , Degeneração Neural/fisiopatologia , Fármacos Neuroprotetores/uso terapêutico , Ataxias Espinocerebelares/tratamento farmacológico , Ataxias Espinocerebelares/fisiopatologia , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Aminopiridinas/farmacologia , Animais , Condicionamento Palpebral/efeitos dos fármacos , Condicionamento Palpebral/fisiologia , Modelos Animais de Doenças , Camundongos , Camundongos Transgênicos , Transtornos das Habilidades Motoras/fisiopatologia , Fármacos Neuroprotetores/farmacologia , Fatores de Tempo
6.
Hum Mol Genet ; 19(23): 4573-86, 2010 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-20829225

RESUMO

A major function of proteasomes and macroautophagy is to eliminate misfolded potentially toxic proteins. Mammalian proteasomes, however, cannot cleave polyglutamine (polyQ) sequences and seem to release polyQ-rich peptides. Puromycin-sensitive aminopeptidase (PSA) is the only cytosolic enzyme able to digest polyQ sequences. We tested whether PSA can protect against accumulation of polyQ fragments. In cultured cells, Drosophila and mouse muscles, PSA inhibition or knockdown increased aggregate content and toxicity of polyQ-expanded huntingtin exon 1. Conversely, PSA overexpression decreased aggregate content and toxicity. PSA inhibition also increased the levels of polyQ-expanded ataxin-3 as well as mutant α-synuclein and superoxide dismutase 1. These protective effects result from an unexpected ability of PSA to enhance macroautophagy. PSA overexpression increased, and PSA knockdown or inhibition reduced microtubule-associated protein 1 light chain 3-II (LC3-II) levels and the amount of protein degradation sensitive to inhibitors of lysosomal function and autophagy. Thus, by promoting autophagic protein clearance, PSA helps protect against accumulation of aggregation-prone proteins and proteotoxicity.


Assuntos
Aminopeptidases/metabolismo , Autofagia , Peptídeos/metabolismo , Aminopeptidases/genética , Animais , Ataxina-3 , Linhagem Celular , Drosophila , Técnicas de Silenciamento de Genes , Humanos , Proteína Huntingtina , Masculino , Camundongos , Proteínas Associadas aos Microtúbulos/genética , Proteínas Associadas aos Microtúbulos/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Fragmentos de Peptídeos/metabolismo , Complexo de Endopeptidases do Proteassoma/metabolismo , Interferência de RNA , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Superóxido Dismutase-1 , alfa-Sinucleína/genética , alfa-Sinucleína/metabolismo
7.
Ann Clin Transl Neurol ; 9(6): 888-892, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35482023

RESUMO

We present a patient who developed, after an early-onset, a stable course of spastic paraplegia and ataxia for 4 decades and eventually succumbed to two episodes of postinfectious lactic acidosis. Diagnostic workup including muscle biopsy and postmortem analysis, oxymetric analysis, spectrophotometric enzyme analysis, and MitoExome sequencing revealed a necrotizing leukoencephalomyelopathy due to the so far unreported biallelic variant of the NDUFV1 gene (p.(Pro122Leu)). This case extends our understanding of NDUFV1 variants with a 14-fold longer lifetime than so far reported cases, and will foster sensitivity toward respiratory chain disease also in adult patients with sudden deteriorating neurological deficits.


Assuntos
Ataxia Cerebelar , Paraplegia Espástica Hereditária , Adulto , Ataxia , Ataxia Cerebelar/genética , Complexo I de Transporte de Elétrons/genética , Humanos , Paraplegia/genética , Paraplegia Espástica Hereditária/genética
8.
J Neurosci ; 29(42): 13126-35, 2009 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-19846700

RESUMO

The B05 transgenic SCA1 mice, expressing human ataxin-1 with an expanded polyglutamine tract in cerebellar Purkinje cells (PCs), recapitulate many pathological and behavioral characteristics of the neurodegenerative disease spinocerebellar ataxia type 1 (SCA1), including progressive ataxia and PC loss. We transplanted neural precursor cells (NPCs) derived from the subventricular zone of GFP-expressing adult mice into the cerebellar white matter of SCA1 mice when they showed absent (5 weeks), initial (13 weeks), and significant (24 weeks) PC loss. Only in mice with significant cell loss, grafted NPCs migrated into the cerebellar cortex. These animals showed improved motor skills compared with sham-treated controls. No grafted cell adopted the morphological and immunohistochemical characteristics of PCs, but the cerebellar cortex in NPC-grafted SCA1 mice had a significantly thicker molecular layer and more surviving PCs. Perforated patch-clamp recordings revealed a normalization of the PC basal membrane potential, which was abnormally depolarized in sham-treated animals. No significant increase in levels of several neurotrophic factors was observed, suggesting, along with morphological observation, that the neuroprotective effect of grafted NPCs was mediated by direct contact with the host PCs. We postulate that a similar neuroprotective effect of NPCs may be applicable to other cerebellar degenerative diseases.


Assuntos
Células-Tronco Adultas/fisiologia , Neurônios/fisiologia , Recuperação de Função Fisiológica/fisiologia , Ataxias Espinocerebelares/cirurgia , Transplante de Células-Tronco/métodos , Células-Tronco Adultas/transplante , Análise de Variância , Animais , Ataxina-1 , Ataxinas , Movimento Celular/fisiologia , Ventrículos Cerebrais/citologia , Dendritos/patologia , Dendritos/fisiologia , Modelos Animais de Doenças , Proteínas de Fluorescência Verde/genética , Força da Mão/fisiologia , Humanos , Potenciais da Membrana/genética , Potenciais da Membrana/fisiologia , Camundongos , Camundongos Transgênicos , Proteínas Associadas aos Microtúbulos/metabolismo , Atividade Motora/genética , Atividade Motora/fisiologia , Mutação , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Neurônios/patologia , Proteínas Nucleares/genética , Técnicas de Patch-Clamp , Peptídeos/genética , Ataxias Espinocerebelares/genética , Ataxias Espinocerebelares/patologia , Ataxias Espinocerebelares/fisiopatologia , Fatores de Tempo
9.
Brain Res ; 1059(2): 189-96, 2005 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-16168392

RESUMO

Regulation of voltage-gated sodium channels is crucial to firing patterns that constitute the output of medium spiny neurons (MSN), projecting neurons of the striatum. This modulation is thus critical for the final integration of information processed within the striatum. It has been shown that the adenylate cyclase pathway reduces sodium currents in MSN through channel phosphorylation by cAMP-dependent protein kinase. However, it is unknown whether a phospholipase C (PLC)-mediated signaling cascade could also modulate voltage-gated sodium channels within MSN. Using the whole-cell patch clamp technique, we investigated the effects of activation of two key components in PLC-mediated signaling cascades: protein kinase C (PKC) and inositol-1,4,5-triphosphate (IP(3)) receptors on voltage-dependent sodium current. Cellular dialysis with phorbol 12-myristate 13-acetate, an activator of PKC, significantly reduced peak sodium current amplitude, while adenophostin A, an activator of IP(3) receptors, significantly increased peak sodium current amplitude. This effect of adenophostin was abolished by calcium chelation or by FK506, an inhibitor of calcineurin. These results suggest an antagonistic role of PKC and IP(3) in the modulation of striatal voltage-gated sodium channels, peak current amplitude being decreased through phosphorylation by PKC and increased through dephosphorylation by calcineurin.


Assuntos
Canais de Cálcio/metabolismo , Neostriado/enzimologia , Neurônios/enzimologia , Receptor Cross-Talk/fisiologia , Receptores de Superfície Celular/metabolismo , Receptores Citoplasmáticos e Nucleares/metabolismo , Canais de Sódio/metabolismo , Potenciais de Ação/fisiologia , Animais , Inositol 1,4,5-Trifosfato/metabolismo , Receptores de Inositol 1,4,5-Trifosfato , Neostriado/citologia , Neurônios/citologia , Proteína Quinase C/metabolismo , Ratos , Ratos Wistar , Receptores de Quinase C Ativada , Transdução de Sinais/fisiologia
10.
Lancet Neurol ; 2(6): 366-74, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12849153

RESUMO

Huntington's disease (HD) is a devastating hereditary neurodegenerative disorder, the progression of which cannot be prevented by any neuroprotective approach, despite major advances in the understanding of its pathogenesis. The study of several animal models of the disease has led to the discovery of both loss-of-normal and gain-of-toxic functions of the mutated huntingtin protein and the elucidation of the mechanisms that underlie the formation of huntingtin aggregates and nuclear inclusions. Moreover, these models also provide good evidence of a role for excitotoxicity and mitochondrial metabolic impairments in striatal neuronal death. Adenosine has neuroprotective potential in both acute and chronic neurological disorders such as stroke or Parkinson's disease. Here we review experimental data on the role of A1 and A2A adenosine receptors in HD that warrant further investigation of the beneficial effects of A1 agonists and A2A antagonists in animal models of HD. Future pharmacological analysis of adenosine receptors could justify the use of A1 agonists and A2A antagonists for the treatment of HDin clinical trials.


Assuntos
Adenosina/uso terapêutico , Doença de Huntington/tratamento farmacológico , Receptor A1 de Adenosina/fisiologia , Receptor A2A de Adenosina/fisiologia , Adenosina/agonistas , Adenosina/antagonistas & inibidores , Agonistas do Receptor A1 de Adenosina , Antagonistas do Receptor A2 de Adenosina , Animais , Corpo Estriado/metabolismo , Modelos Animais de Doenças , Humanos , Doença de Huntington/genética , Doença de Huntington/fisiopatologia , Doenças Mitocondriais/complicações , Doenças Mitocondriais/tratamento farmacológico , Doenças Mitocondriais/metabolismo , Modelos Moleculares , Modelos Neurológicos , Mutação , Redes Neurais de Computação , Fármacos Neuroprotetores/uso terapêutico , Receptores Dopaminérgicos/metabolismo
11.
Neurosci Lett ; 367(2): 171-6, 2004 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-15331146

RESUMO

Cerebellar Purkinje cells receive two different excitatory inputs from parallel and climbing fibers, causing simple and complex spikes, respectively. Purkinje cells present three modes of simple spike firing, namely tonic, silent and bursting. The influence of complex spike firing on simple spike firing has been extensively studied. However, it is unknown whether and how the simple spike firing mode may influence complex spike waveform and firing rate in vivo. We studied complex spike firing during tonic and silent mode periods in non-anesthetized mice. We found that complex spike firing rate is not influenced by simple spike firing modes, but that the complex spike waveform is altered following high frequency simple spike firing. This alteration is a specific decrement of the second depolarizing component of the complex spike. We demonstrate that the amplitude of the second depolarizing component is inversely proportional to the simple spike firing rate preceding the complex spike and that this amplitude is independent of previous complex spike firing. This waveform modulation is different from previously reported modulation in paired-pulse depression and refractoriness.


Assuntos
Potenciais de Ação/fisiologia , Cerebelo/citologia , Potenciais Evocados/fisiologia , Células de Purkinje/fisiologia , Vigília/fisiologia , Potenciais de Ação/efeitos da radiação , Animais , Estimulação Elétrica/métodos , Potenciais Evocados/efeitos da radiação , Camundongos , Camundongos Endogâmicos C57BL , Inibição Neural/fisiologia , Inibição Neural/efeitos da radiação , Células de Purkinje/classificação , Fatores de Tempo
13.
Neurosci Lett ; 455(1): 4-7, 2009 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-19429095

RESUMO

Purkinje cells (PCs) are the sole output from the cerebellar cortex. Their electrophysiological behavior may serve as indicator of chronic ethanol effects on the cerebellum. Here, we studied the effects of ethanol consumption through breastfeeding on motor behavior, histology and PCs electrophysiology. Mice with different maternal drinking regimen (ethanol, E or sucrose, S) during prenatal (E/and S/) and postnatal period (/E and/S) were compared. Motor performance in the runway and rotarod tests was significantly worse in mice exposed to ethanol prenatally (E/E and E/S) than in mice exposed to sucrose (S/S), with a limited influence, if any, of mother regimen during lactation (E/S vs E/E). A loss of 20-25% of PCs was found for both E/S and E/E compared to S/S mice but PC numbers were similar in S/E and S/S. Mean PC spontaneous simple spike firing rate and rhythmicity were higher in E/S and E/E than in S/S but there was no difference between S/E and S/S. Complex spike frequency was similar in all groups. In contrast, complex spike duration and the related pause induced on the simple spike firing were shorter in E/E and in E/S, but no difference was found between S/E and S/S. We conclude that cerebellar dysfunction induced by maternal ethanol consumption in mice depends upon the drinking regimen during pregnancy and not during lactation.


Assuntos
Consumo de Bebidas Alcoólicas/efeitos adversos , Cerebelo/fisiopatologia , Transtornos do Espectro Alcoólico Fetal/fisiopatologia , Lactação , Exposição Materna , Córtex Motor/fisiopatologia , Células de Purkinje/fisiologia , Potenciais de Ação , Consumo de Bebidas Alcoólicas/patologia , Consumo de Bebidas Alcoólicas/fisiopatologia , Animais , Animais Recém-Nascidos , Cerebelo/patologia , Feminino , Transtornos do Espectro Alcoólico Fetal/patologia , Camundongos , Atividade Motora , Córtex Motor/patologia , Periodicidade , Gravidez , Efeitos Tardios da Exposição Pré-Natal/patologia , Efeitos Tardios da Exposição Pré-Natal/fisiopatologia , Células de Purkinje/patologia
14.
Proc Natl Acad Sci U S A ; 104(23): 9858-63, 2007 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-17535929

RESUMO

In cerebellum and other brain regions, neuronal cell death because of ethanol consumption by the mother is thought to be the leading cause of neurological deficits in the offspring. However, little is known about how surviving cells function. We studied cerebellar Purkinje cells in vivo and in vitro to determine whether function of these cells was altered after prenatal ethanol exposure. We observed that Purkinje cells that were prenatally exposed to ethanol presented decreased voltage-gated calcium currents because of a decreased expression of the gamma-isoform of protein kinase C. Long-term depression at the parallel fiber-Purkinje cell synapse in the cerebellum was converted into long-term potentiation. This likely explains the dramatic increase in Purkinje cell firing and the rapid oscillations of local field potential observed in alert fetal alcohol syndrome mice. Our data strongly suggest that reversal of long-term synaptic plasticity and increased firing rates of Purkinje cells in vivo are major contributors to the ataxia and motor learning deficits observed in fetal alcohol syndrome. Our results show that calcium-related neuronal dysfunction is central to the pathogenesis of the neurological manifestations of fetal alcohol syndrome and suggest new methods for treatment of this disorder.


Assuntos
Etanol/toxicidade , Transtornos do Espectro Alcoólico Fetal/fisiopatologia , Plasticidade Neuronal/efeitos dos fármacos , Células de Purkinje/efeitos dos fármacos , Sinapses/efeitos dos fármacos , Animais , Western Blotting , Cálcio/metabolismo , Canais de Cálcio/metabolismo , Feminino , Imuno-Histoquímica , Potenciação de Longa Duração/efeitos dos fármacos , Camundongos , Técnicas de Patch-Clamp , Gravidez , Proteína Quinase C/metabolismo , Teste de Desempenho do Rota-Rod
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA